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ABSTRACT
The primary aim of this systematic review was to assess the evidence on periodontal disease 
progression after treatment in patients receiving supportive periodontal therapy (SPT) and 
to identify predictors of clinical attachment level (CAL) loss. A protocol was developed to 
answer the following focused question: In adult patients treated for periodontitis, what 
is the disease progression in terms of CAL loss after surgical or non-surgical treatment? 
Randomized controlled clinical trials, prospective cohort studies, and longitudinal 
observational human studies with a minimum of 5 years of follow-up after surgical or non-
surgical treatment that reported CAL and probing depth changes were selected. Seventeen 
publications reporting data from 14 investigations were included. Data from 964 patients 
with a follow-up range of 5–15 years was evaluated. When the CAL at the latest follow-up was 
compared to the CAL after active periodontal therapy, 10 of the included studies reported 
an overall mean CAL loss of ≤0.5 mm, 3 studies reported a mean CAL loss of 0.5–1 mm, and 
4 studies reported a mean CAL loss of >1 mm. Based on 7 publications, the percentage of 
sites showing a CAL loss of ≥2 mm varied from 3% to 20%, and a high percentage of sites 
with CAL loss was associated with poor oral hygiene, smoking, and poor compliance with 
SPT. The outcomes after periodontal therapy remained stable over time. Disease progression 
occurred in a reduced number of sites and patients, mostly associated with poor oral hygiene, 
poor compliance with SPT, and smoking.
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INTRODUCTION
Periodontitis is defined as a chronic multi-factorial inflammatory disease associated 
with dysbiotic plaque biofilms and characterized by progressive destruction of the tooth-
supporting apparatus. Its primary features include the loss of periodontal tissue support, 
manifested through clinical attachment level (CAL) loss, radiographically assessed alveolar 
bone loss, the presence of periodontal pocket and gingival bleeding [1].
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The progression of periodontal disease is relevant for understanding its etiopathogenesis and 
clinical manifestations. Longitudinal studies have revealed that in the absence of treatment, 
disease progression is a relatively rare event that occurs through increased pocket depth in a 
small number of subjects, primarily at interproximal sites of molar teeth, while mid-buccal 
sites experience a higher incidence of recession [2-9].
The definition of disease progression has varied in the available literature, from a CAL 
loss of ≥2 mm [10,11] to a loss of ≥3 mm [12]. Most information available on disease 
progression is based on longitudinal studies that have evaluated patients that did not 
undergo periodontal therapy and were followed for different periods of time [9,13]. 
Recent longitudinal studies that have followed healthy and untreated diseased subjects 
have provided relevant insights into the disease mechanisms of periodontitis. Teles and 
colleagues [14] followed 113 periodontally healthy patients and 302 periodontitis patients 
for 12 months and concluded that only a small number of the evaluated sites (0.7%) were 
classified as progressing and that many more shallow sites progressed than did deeper 
sites (387 vs. 15). Moreover, in an analysis of the differences in disease progression between 
healthy and diseased subjects, 51.4% of the sites that were considered to be active belonged 
to the patients diagnosed with severe disease, 33.4% to those who were diagnosed with 
moderate disease, and 15.2% to healthy patients, indicating that progression mainly 
occurred at shallow sites in diseased patients. This observation suggested that clinicians 
should focus on the entire disease process that affects the patient, rather than only on the 
deep sites [14].
Similar findings were reported in a recent systematic review finding that the mean annual 
CAL change was highly variable, with a mean annual CAL loss of 0.1 mm. Interestingly, only 
geographic location or ethnic status (a proxy for socioeconomic status) showed evidence of a 
statistically significant effect on mean attachment change [15].
Although this information is certainly pertinent for the understanding of periodontal 
disease, and also necessary to establish new avenues of treatment and diagnostic tools, it may 
not necessarily apply to patients who have already undergone therapy.
The goals of periodontal therapy are arresting disease progression, reducing the risk of tooth 
loss, restoring tissues that have been lost as a result of disease, and finally, preventing its 
recurrence [16]. Surgical and non-surgical treatments of periodontitis have achieved positive 
clinical outcomes, as described in published systematic reviews [17-20]. Similarly, supportive 
periodontal therapy (SPT) has been shown to be effective in maintaining periodontal health 
and preventing tooth loss in patients with periodontitis [21-24].
In spite of this high predictability, several patient- and tooth-related factors have been 
associated with tooth loss during SPT, such as age, smoking, and the presence of furcations 
[25]. However, information on other predictors of disease progression in subjects who have 
received periodontal therapy and are under SPT is rather scarce, and there is limited evidence 
on systemic or local factors that may contribute to CAL loss [26].
The purpose of this review was therefore: 1) to systematically assess the available evidence 
on periodontal disease progression, defined as CAL loss, in patients who have been treated 
for periodontitis and are under SPT; and 2) to further identify predictors of CAL loss among 
these patients.
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PROTOCOL DEVELOPMENT AND FOCUSED QUESTION
The study protocol was designed prior to the start of the review according to the Preferred 
Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement [27]. The 
protocol aimed at answering the following focused question: In adult patients treated for 
periodontitis (population), what is the disease progression in terms of CAL loss (primary 
outcome) after surgical or non-surgical treatment?
Eligibility criteria
• Population: patients older than 18 diagnosed and treated for periodontitis under SPT.
• Intervention: surgical or non-surgical periodontal therapy.
• Comparison: surgical versus non-surgical therapy, different modalities of surgical and 
non-surgical therapy in controlled studies.
• Outcome: disease progression (defined as CAL loss).
• Study design: randomized controlled trials (RCTs), prospective cohort studies and 
prospective case series with a minimum of 10 patients (5 per group in controlled studies).
Exclusion criteria
• Review or preclinical studies
• Studies with less than 5 years of follow-up
• Retrospective studies
• Studies aiming at regenerating the periodontum
• Studies with unspecified or unstandardized treatments
• Studies reporting on specific populations, such as patients with diabetes
• Studies reporting on early-onset periodontitis or refractory periodontitis
Types of interventions and comparisons
The present review considered any surgical or non-surgical interventions and any possible 
comparisons among them.
Type of outcomes
The primary outcome was CAL change. The following secondary outcomes were studied:
• Radiographic bone loss measured on peri-apical radiographs
• Tooth loss
• Age, demographics, socioeconomic status, and lifestyle
INFORMATION SOURCES AND SEARCH
Electronic search
Three electronic databases were used as sources in the search for publications: 1) The 
National Library of Medicine (MEDLINE via PubMed); 2) Embase; and 3) the Cochrane 
Central Register of Controlled Trials. These databases were searched for articles published 
through November 2018. The search was limited to human subjects.
https://doi.org/10.5051/jpis.2019.49.2.60
Periodontal disease progression after treatment
https://jpis.org 62
Manual search
All reference lists of the selected publications were checked for cross-references. In addition, 
the following journals were hand-searched from the year 2005 to 2018: Journal of Clinical 
Periodontology, Journal of Periodontology, Clinical Oral Implants Research, Journal of Periodontal Research, 
and Journal of Dental Research and Clinical Oral Investigations.
Search strategy
Key words, MesH terms, and free terms were used to conduct the search while Boolean 
operators (OR, AND) were used to combine the searches. The search strategy was limited to 
human studies and the English language, and the search applied was the following:
(scaling and root planing) OR (basic periodontal therapy) OR (non surgical periodontal therapy)
(periodontal access flap surgery) OR (open flap debridement) OR (osseous resective surgery) 
 OR (modified widman flap) OR (periodontal access surgery)
(#1) OR (#2)
(periodontal disease progression) OR (disease progression) [mh] OR (clinical attachment level) 
 OR (periodontal attachment loss) [mh] OR (treatment outcomes) [mh] OR (longitudinal studies) [mh]
(#3) AND (#4)
(periodontal regeneration) OR (peri-implantitis) [mh]
(#5) NOT (#6)
Screening methods
Two reviewers (ISS and SWY) conducted the primary search by independently screening 
the titles and abstracts. The same reviewers selected the full manuscripts of investigations 
meeting the eligibility criteria, or those with insufficient data in the title and abstract to make 
a clear decision. Any disagreement was resolved by discussion with a third reviewer (JKC). 
The inter-reviewer reliability (percentage of agreement and kappa correlation coefficient) of 
the full-text analysis was calculated.
Data extraction
The same 2 reviewers performed duplicate data extraction. When data were incomplete or 
missing, authors of the publications were contacted for clarification. If agreement could not 
be reached, data were excluded until further clarification was available. When the results of a 
study were published more than once, only the longest follow-up was included, unless there 
were different outcomes of interest.
Quality assessment (risk of bias in individual publications)
The quality of the included publications was assessed by 1 reviewer (SWY) following the 
recommendations of the Cochrane Collaboration [28]. The following items were evaluated to 
generate an overall assessment of low, high, or unclear risk of bias: selection bias (sequence 
generation and allocation concealment), performance bias (blinding of participants/personnel), 
detection bias (blinding of outcome assessment), attrition bias (incomplete outcome data), 
selective reporting bias (selective reporting outcomes), and finally other potential sources of bias. 
Furthermore, the Newcastle-Ottawa Scale for cohort studies and a modification of the scale for 
cross-sectional studies were used to assess the risk of bias in individual observational studies [29].
Data analyses
Data were pooled into tables and the publications were grouped according to the type of 
studies and interventions. A descriptive summary was created to determine the quantity of 
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the data and to analyze the characteristics and results of each publication. This enabled a 
confirmation of the similarities of the publications, the reported outcomes, the subgroups, 
and the predictors analyzed (site-, tooth-, or patient-related factors).
RESULTS
Search and publication characteristics
Figure 1 presents a flow chart summarizing the results of the selection process. The electronic 
search provided a total of 1,931 titles/abstracts. Out of these, 1,894 were excluded (inter-
reader agreement, 98.4%; κ=0.47; P<0.001; 90% confidence interval [CI], 0.33–0.59). The 
resulting number of obtained full-text articles was 37. The hand search provided 20 additional 
publications, resulting in an overall number of 57 full-text articles. Out of these, 40 were 
excluded (inter-reader agreement, 91.2%; κ=0.80; P<0.001; 90% CI, 0.62–0.95). Finally, 17 
publications belonging to 14 investigations met the eligibility criteria and were included. The 
reasons for excluding studies after full-text review are detailed in Supplementary Table 1. 
Briefly, the reasons were: no CAL values (n=13), a non-prospective design (n=6), follow-up 
<5 years (n=7), inclusion of <10 patients (n=2), unstandardized/unclear treatment (n=5), and 
irrelevance (n=7).
Quality assessment of the included publications
Twelve of the included studies were RCTs. Five studies had a non-randomized design. In 
addition, 1 RCT provided follow-up data [30] and 2 RCTs were coupled with additional 
publications that provided further outcome data from the same follow-up period [31,32]. The 
full checklist from the Cochrane Collaboration tool for assessing the risk of bias was applied 
for RCTs. Among the 9 randomized studies with 12 publications, 2 publications were part II 
of the same follow-up and were not included in the table. One of the studies was considered 
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Excluded title or abstract
(n=1,894)
Excluded articles
(n=40)
Potentially relevant publications identified 
through electronic search
(n=1,931)
Potentially relevant publications
identified for full-text analysis
(n=37)
Articles included by hand search
(n=20)
Full-text analysis
(n=57)
Articles included in the review
(n=17)
Reporting data from 14 investigations
Figure 1. Flow chart depicting the search strategy and study selection process.
to have a moderate risk of bias and the remaining studies were considered to have a high risk 
of bias (Table 1). The quality assessment of the non-randomized studies using the Newcastle-
Ottawa Scale can be found in Supplementary Table 2.
Description of the included publications
A total of 964 patients were evaluated in the present systematic review, with the minimum 
number of subjects reported being 10 patients [32,33] and the maximum being 334 patients 
[34]. The follow-up ranged from 5 to 15 years [35], with 3 publications reporting data from 
more than 10 years of follow-up.
Interventions
Table 2 depicts the methodological characteristics of the selected studies. Three 
publications reported interventions involving periodontal surgery, 3 reported non-surgical 
approaches, and 11 publications reported comparisons between surgical and non-surgical 
therapy. The most utilized periodontal surgical intervention was the modified Widman 
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Table 1. Risk of bias of randomized studies according to the Cochrane Collaboration recommendations (Higgins and Green, 2011)
References Selection bias Performance  
bias
Detection  
bias
Attrition  
bias
Selective 
reporting bias
Other potential 
risk of biasSequence 
generation
Allocation 
concealment
Crespi et al. (2011) [35] High High High High High Low Low
Gaspirc & Skaleric (2007) [57] High High High High Low High Low
Kaldahl et al. (1996) [43] High High High High High High High
Lindhe et al. (1984) [42] High High High High High Low Low
Pihlstrom et al. (1983) [32] High High High High High Low High
Preus et al. (2017) [36] Low Low High High Low High Low
Ramfjord et al. (1975) [56] High High High High Low Low Low
Knowles et al. (1979) [30] High High High High Unclear High High
Ramfjord et al. (1987) [41] High High High High High Low Low
Serino et al. (2001) [40] High High High High High Low Low
Table 2. Methodological characteristics and outcomes measured by the included studies
Authors (year) Reference Intervention Design FU (yr) Patients Test Control Other 
treatments
Outcomes
Axelsson & Lindhe (1981) [38] Surgery PCS 6 25 MWF PI, GI, PD, CAL
Crespi et al. (2011) [35] Surgery RCT split 15 25 FOS+CO2L MWF PI, GI, PD, CAL
Gaspirc & Skaleric (2007) [57] Surgery RCT split 5 25 MWF+Er:YAG MWF GI, PI, BOP, PD, REC, CAL
Isidor & Karring (1986) [39] Surgical/non-surgical CCT 5 16 MWF SRP RBF PI, GI, PD, CAL
Kaldahl et al. (1996) [43] Surgical/non-surgical RCT 7 51 FOS MWF SRP, CSC PI, PD, CAL, BOP, REC, SUP, TL
Kaldahl et al. (1996) [31] Surgical/non-surgical RCT 7 51 FOS MWF SRP, CSC PD, CAL
Lindhe et al. (1984) [42] Surgical/non-surgical RCT split 5 11 MWF SRP CAL, PD
Pihlstrom et al. (1983) [32] Surgical/non-surgical RCT split 6.5 10 MWF SRP CAL, PD
Pihlstrom et al. (1984) [33] Surgical/non-surgical RCT split 6.5 10 MWF SRP CAL, PD, TL
Preus et al. (2017) [36] Non-surgical RCT 5 161 SRP+MET SRP+PL FMDIS+PL, 
FMDIS+MET
PI, BOP, PD, CAL
Ramberg et al. (2001) [37] Non-surgical CCT 5 115 SRP+TTR SRP PI, BOP, CAL, PD, RX
Ramfjord et al. (1975) [56] Surgical/non-surgical RCT split 5 79 MWF CUR PE CAL, PD
Knowles et al. (1979) [30] Surgical/non-surgical RCT split 8 43 MWF CUR PE CAL, PD
Ramfjord et al. (1987) [41] Surgical/non-surgical RCT split 5 72 MWF SRP PE, CUR CAL, PD, TL
Renvert et al. (1996) [55] Surgical/non-surgical CS 5 12 MWF SRP CAL, PD, Micro
Rosling et al. (2001) [34] Non-surgical PCS 12 334 SRP CAL, PD, PI, TL, RX
Serino et al. (2001) [40] Surgical/non-surgical RCT 13 64 MWF SRP CAL, BOP, PD, RX
BOP: bleeding on probing, CAL: clinical attachment level, CCT: Controlled clinical trial, CO2L, CO2 laser, CS: case series, CSC: coronal scaling, CUR: curettage, 
FU: follow-up, FOS: flap osseous surgery, FMDIS: full mouth disinfection, GI: gingival index, MET: metronidazole, Micro: microbiology, MWF: modified Widman 
flap, PCS: prospective cohort study, PD: probing depth, PE: pocket elimination, PL: placebo, PI: plaque index, RBF: reverse bevel flap, RCT: randomized 
controlled trial, REC: recession, RX: radiograph, SRP: scaling and root planing, SUP: suppuration, TL: tooth loss, TTR: tetracycline.
flap (MWF), which was reported in 14 publications, whereas 5 publications reported on 
different modalities of flap osseous surgery (FOS). Among the publications that evaluated 
non-surgical therapy, 12 publications utilized scaling and root planning (SRP), of which 
2 publications utilized systemic antibiotics (metronidazole or tetracycline) as adjunctive 
therapy [36,37].
SPT
SPT was reported in all studies. The reported recall program varied significantly, although 
most investigations included an intensive period of recall after treatment that lasted 6–24 
months and was followed by a regular recall program with appointments every 3, 4, or 6 
months (Table 3).
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Table 3. Periodontal disease progression as reported in the different studies
Publication SPT PD CAL Frequency distributions
Axelsson & 
Lindhe (1981) 
[38]
One-third patients 
received maintenance by 
dentist (NRG). Two-third 
university program with 1 
appointment per 2 mon 
the first 2 yr and then 1 
appointment per 3 mon 
after (RG).
NRG: 1.8±0.24 (BS) to  
2.9±0.51 (6 yr).
NRG: 3.7±1.11 (BS) to  
5.5±1.11 (6 yr).
PD: 18% increase of 4–6 mm  
at 6 yr in NRG.
RG: 1.9±0.32 (BS) to  
1.6±0.35 (6 yr).
RG: 4.2±0.90 (BS) to  
4.0±0.93 (6 yr).
Among sites with CAL loss: NRG; 
44% ≤1 mm, 55% 2–5 mm, and  
1% ≥6 mm. RG; 99% ≤1 mm,  
1% 2–5 mm.
Crespi et al. 
(2011) [35]
Patients were recalled 
every 2 wk for 3 mon and 
twice a yr thereafter.
Change BS-15 yr Change BS-15 yr NR
i) 1–4 mm; MWF: 0.61 mm, LT: 0.35 mm. i) 1–4 mm; MWF: −0.39 mm, LT: −0.38 mm.
ii) 5–6 mm; MWF: 0.03 mm, LT: 0.3 mm. ii) 5–6 mm; MWF: −0.24 mm, LT: 0.3 mm.
iii) ≥7 mm; MWF: 0.95 mm, LT: 0.4 mm. iii) ≥7 mm; MWF: −0.94 mm, LT: 0.37 mm.
Gaspirc & 
Skaleric 
(2007) [57]
SPT 1/mon for 3 mon and 
at mon 6 post-surgery, 
then 1/6 mon during the 
remainder of the study.
MW: 2.92±0.7 mm (BS) to  
2.91±0.55 mm (5 yr)
MW: 3.81±1.06 mm (BS) to  
4.05±0.85 mm (5 yr)
NR
LT: 2.82±0.70 mm (BS) to  
2.84±0.43 mm (5 yr)
LT: 3.66±0.81 mm (BS) to  
3.97±0.89 mm (5 yr)
Isidor & 
Karring 
(1986) [39]
First yr 1 professional 
cleaning every 2 wk.
MWF: 2.3 mm (BS), 3.1 mm (5 yr). Change BS-5 yr Eighteen surfaces (7.1%) in MWF and 
7 surfaces in SRP (2.9%) showed ≥2 
mm loss of CAL. Overall 48 surfaces 
(4.9%) showed an attachment loss 
of ≥2 mm after 5 yr.
During 2nd yr 1/3 mon 
from then every 6 mon.
SRP: 3.1 mm (BS), 3.2 mm (5 yr). MWF: −0.2mm, SRP: 0.4 mm
Kaldahl et al. 
(1996) [43]
1/3 mon after surgery, 
plaque control, OHI,  
CSC, SRP if necessary.
Change BS-7 yr Change BS-7 yr Tooth loss: 19 originally treated 
with CSC, 21 with SRP, 20 with MWF, 
and 5 teeth treated with FOS were 
extracted due to probing depth 
progressing past the apex.
i)  1–4 mm; SRP: 0 mm,  
MWF: 0.2 mm, FOS: 0.5 mm.
i)  1–4 mm; SRP: −0.3 mm,  
MWF: −0.5 mm, FOS: 0.1 mm.
ii)  5–6 mm; SRP: 0.2 mm,  
MWF: 0.2 mm, FOS: 0.6 mm.
ii)  5–6 mm; SRP: 0 mm,  
MWF: −0.1 mm, FOS: 0.1 mm.
iii)  ≥7 mm; SRP: −0.4 mm,  
MWF: 0.1 mm, FOS: 0.5 mm.
iii)  ≥7 mm; SRP: 0.3 mm, MWF: 0.1 mm, 
FOS: 0.1 mm.
Kaldahl et al. 
(1996) [31]
One-third mon after 
surgery, plaque control, 
OHI, CSC, SRP if 
necessary.
Reported in Kaldahl et al. (1996) [43] Reported in Kaldahl et al. (1996) [43] Breakdown defined ≥3 mm CAL loss. 
35 patients had ≤0.99% sites with 
breakdown, 34 patients 1%–3% 
sites, 8 patients 3%–6% sites. 
Patients having an incidence of a 
>3.00% were smokers at BS.
Lindhe et al. 
(1984) [42]
For first 6 months 
professional tooth 
cleaning once/2 wk, next 
18 mon once/3 mon. After 
this SRP was avoided and 
SPT were every 4–6 mon.
MWF: ±1 mm, 76% sites; +2 mm,  
14%; −2 mm, 7%.
MWF: ±1 mm, 84% sites; −2 mm,  
9%; −2 mm, 5%.
CAL gains of ≥2 mm in 2% sites.  
CAL loss ≥2 mm in 10%–12% of sites. 
Patients with poor oral hygiene had 
20% of sites loss ≥2 mm while in 
good oral hygiene only 2%–3% sites.
SRP: ±1 mm, 84% sites; −2 mm,  
9%; +2 mm, 5%.
SRP: ±1 mm, 85% sites; −2 mm,  
7%; +2 mm, 7%.
Pihlstrom et 
al. (1983) [32]
Three to 4 times per year. 
OHI, CSC and SRP for 1 hr.
MWF: 1–3 mm, 0.3mm; 4–6 mm,  
0.4 mm; >7 mm, 0.7 mm.
MWF: 1–3 mm, 0.1 mm; 4–6 mm,  
0.2 mm; >7 mm, −0.2 mm.
NR
SRP: 1–3 mm, 0.2 mm; 4–6 mm,  
0.05 mm; >7 mm, 0.2 mm.
SRP: 1–3 mm, 0.1 mm; 4–6 mm,  
0.3 mm; >7 mm, 0.3 mm.
(continued to the next page)
Primary outcome
The primary outcome was assessed by CAL measurements or by the frequency distribution 
of sites with attachment loss at the most recent follow-up appointment. The majority of 
the studies reported CAL values according to the different treatment modalities, although 
some studies stratified CAL values according to other factors, such as the type of recall [38], 
smoking [31] and patients' susceptibility [34].
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Publication SPT PD CAL Frequency distributions
Pihlstrom et 
al. (1984) [33]
Three to 4 times per yr. 
OHI, CSC and SRP for 1 hr.
Change BS-6.5 yr Change BS-6.5 yr NR
i)  4–6 mm: MWF: Mol: 0.7, non-Mol: −0.31. 
SRP: Mol: −0.21, non-Mol: 0.3.
4–6 mm: MWF: Mol: −0.06, non-Mol: 0.41. 
SRP: Mol: 0.21, non-Mol: 0.29.
ii)  >7 mm: MWF: Mol: 0.48, non-Mol: −0.3. 
SRP: Mol: 0.74, non-Mol: −0.45
>7 mm: MWF: Mol: −0.38, non-Mol: −0.3. 
SRP: Mol: −0.13, non-Mol: 0.5
Preus et al. 
(2017) [36]
SPT at 3, 6, and 12 mon 
after therapy, and every 
6 mon after that. SPT 
consisted of CSC and SRP 
and sites that required it.
Change BS-5 yr Change BS-5 yr Trend for increase in the number 
of teeth with PPD ≥5 mm noted, 
occurrence of PPD ≥5 mm remained 
stable.
FMDIS-MET: 0.2 mm, FDIS: 0.15 mm, 
SRP+MET: 0.17 mm, SRP: 0.21 mm.
FMDIS-MET: −0.53 mm, FDIS: −0.47 mm, 
SRP+MET: −0.74 mm, SRP: −0.44 mm.
TL: None, 45%; 1 TL, 24%; 2 TL,  
14%; 3 TL, 9%; ≥4 TL, 8%.
Ramberg et 
al. (2001) 
[37]
SPT 3–4 times per yr. Change BS-13 yr Change BS-13Y: TTR: −1mm, SRP: −1.1mm PD; BS
TTR(test): 0.4 mm, SRP(control): 0.3mm ≤3 mm: test, 43%; control, 49%;  
4–6 mm: test, 42%; control, 39%;  
≥7 mm: test, 15%; control, 12%.
13 yr
≤3 mm: test, 57%; control, 61%;  
4–6 mm: test, 35%; control,  
32%; ≥7 mm: test, 8%; control, 7%.
Ramfjord et 
al. (1975) [56]
SPT every 3 mon. Change in interproximal mean PPD: CUR, 
−0.3mm; MWF, −0.4 mm; PEL, −0.58 mm.
Change in mean interproximal CAL: CUR, 
0.38 mm; MWF, −0.02 mm; PEL, −0.06 mm.
NR
Knowles et 
al. (1979) 
[30]
SPT every 3 mon. Overall change in PD: 1–3 mm, −0.35 mm; 
4–6 mm, −0.3 mm; ≥7 mm, −0.2 mm.
Overall change in CAL: 1–3 mm, −0.3 mm; 
4–6 mm, 0.25 mm; ≥7 mm, −0.4 mm.
NR
Ramfjord et 
al. (1987) [41]
Once per wk for 4 wk 
post-surgically,  
and later once 1/3 mon 
for 5 yr.
BS-5 yr Change BS-5 yr in mm % Sites CAL loss ≥2 mm
i)  1–3 mm; PEL: 0.43, CUR: 0.1,  
MWF: 0.17, SRP: 0.03.
i)  1–3 mm; PEL: −0.53, CUR: −0.64,  
MWF: −0.56, SRP: 0.62.
i)  1–3 mm, PEL: 38.1, CUR: 33.6,  
MWF: 35.4, SRP: 30.3.
ii)  4–6 mm; PEL: −0.52, CUR: −0.65,  
MWF: 0.39, SRP: 0.18.
ii)  4–6 mm; PEL: −0.49, CUR: −0.42,  
MWF: −0.43, SRP: −0.57.
ii)  4–6 mm; PEL: 29.3, CUR: 22.6,  
MWF: 27.9, SRP: 21.1.
iii)  ≥7 mm; PEL: −0.64, CUR: 1.29,  
MWF: 0.28, SRP: −0.07.
iii)  ≥7 mm; PEL: 0.26, CUR: 0.4,  
MWF: 0.5, SRP: 0.4.
iii)  ≥7 mm; PEL: 10.8, CUR: 10.9,  
MWF: 8.1, SRP: 14.8.
Renvert et al. 
(1996) [55]
One-third mon for 3 yr 
and thereafter every 6 
mon. Plaque scores,  
OHI, CSC, no SRP.
PD change BS-5 yr: 1.4 mm CAL change BS-5 yr: −0.5 mm NR
Rosling et al. 
(2001) [34]
Three to 4 times per year, 
according to individual 
needs. OHI, BOP, PD.
% of molar sites exhibiting  
an increase in PD ≥2 mm
CAL change: NG: 0.45 mm, HSG: 0.8 mm NG 10% of subjects had 8 teeth 
exhibiting ≥2 mm CAL loss. 70% of 
HSG subjects had >8 teeth with ≥2 
mm CAL change.
i) 0–3 mm; NG: 4.6%, HSG: 34.3%.
ii) 4–5 mm; NG: 2.4%, HSG: 25.6%.
iii) ≥6 mm; NG: 16.1%, HSG: 18.1%.
Serino et al. 
(2001) [40]
SPT 4 times per 
year. Plaque control. 
Additional SRP at sites 
≥5 mm.
PD change BS-13 yr Mean annual CAL loss Annual % of sites ≥2 mm CAL loss 
stratified by PD CAL loss in PD ≥6 mm
SRP: 0.6 mm, MWF: 0.6 mm. i)  SRP: 0.08 mm (1–3 yr), 0.11 mm (3–5 yr), 
and 0.07 mm (5–13 yr).
i)  SRP: 7.5% (1–3 yr), 7.8% (3–5 yr),  
2.9% (5–13 yr).
ii)  MWF: 0.11 mm (1–3 yr), 0.07mm (3–5 yr), 
0.07mm (5–13 yr).
ii)  MWF: 5% (1–3 yr), 4% (3–5 yr),  
2.3% (5–13 yr).
Baseline was considered to be the first examination after the completion of active therapy.
Aa: Actinobacillus actinomycetemcomitans, BOP: bleeding on probing, BS: baseline, CAL: clinical attachment level, CSC: coronal scaling, CUR: curettage, FMDIS: 
full mouth disinfection, FOS: flap osseous surgery, FU: follow-up, HSG: high susceptibility group, LT: laser therapy, MET: metronidazole, Micro: microbiology, Mol: 
molar, MWF: modified Widman flap, NG: normal group, NR: not reported, NRG: non-recall group, OHI: oral hygiene instructions, PD: probing depth, PEL: pocket 
elimination surgery, PG: Porphyromonas gingivalis, RG: recall group, SPT: supportive periodontal therapy, SRP: scaling and root planing, TL: tooth loss, TTR: 
tetracycline.
Table 3. (Continued) Periodontal disease progression as reported in the different studies
Of the studies that compared CAL at the most recent follow-up to CAL after active 
periodontal therapy (surgical or non-surgical), 10 reported a mean CAL loss of ≤0.5 mm, 3 
reported a mean CAL loss from 0.5 to 1 mm, and 4 reported a mean CAL loss of >1 mm.
Seven publications provided information on the frequency distribution of sites with attachment 
loss [24,31,34,38-41]. Among them, only 1 reported the number of patients who lost 
attachment, in addition to the site analysis [31]. Five studies reported the frequency of sites that 
lost ≥2 mm, while 1 publication used a cut-off value of 3 mm [31] and 1 publication reported the 
percentage of sites with ≤1 mm, 2-5 mm, and ≥6 mm of CAL loss [38]. The percentage of sites 
showing ≥2 mm of CAL loss varied from 3% [39] to 20% [34,42]. Several factors were identified 
as influencing CAL loss; in patients with poor oral hygiene (defined as a low frequency of sites 
with plaque free surfaces), 20% of sites had ≥2 mm of CAL loss [42] and smokers presented 
a disproportionately high percentage of sites with ≥3 mm of CAL loss [31]. Two of the 7 
publications allowed for re-instrumentation at sites where disease progression was detected, 
and therefore reported the yearly incidence of breakdown sites [31,40].
Four studies stratified CAL loss based on baseline probing depth (PD), with no apparent differences 
with regard to disease progression between the different levels of PD [31,40-42] (Table 3).
Most investigations found few long-term differences in the mean change of CAL between 
sites treated by SRP and MWF. One publication, however, found that SRP-treated subjects 
exhibited more signs of advanced disease progression in the 1–3 years period following 
active therapy than MWF-treated subjects [40]. Another publication found that MWF led 
to a greater sustained gain in CAL than curettage in sites with ≥7 mm of CAL [30], while 
another publication demonstrated that SRP led to a greater long-term gain of CAL than MWF 
in sites with 4–6 mm depths [32]. Regarding the utilization of FOS, the initial changes that 
occurred after surgery led to a more pronounced CAL loss, since greater recession occurred. 
Nonetheless, no evident differences were observed when analyzing CAL changes after 
treatment between sites that underwent SRP or MWF compared to FOS [43].
The utilization of systemic antibiotics as adjuncts to SRP, as reported in 2 publications, did not 
appear to have an additional benefit in terms of CAL changes after 5 years of therapy [37,44].
Finally, 4 publications evaluated CAL changes based on proximal or interproximal surfaces 
[24,30,38,40] and 3 studies stratified molar versus non-molar sites [33,34,36], reaching an 
overall agreement that interproximal sites and molar sites presented higher amount of CAL loss.
Secondary outcomes
PD was reported in the studies as described for CAL. Nine studies reported the mean PD 
values at baseline (after completion of active periodontal therapy) and the most recent 
follow-up or mean PD changes. Among them, 5 studies reported a mean PD change of ≤0.5 
mm, 2 studies reported changes between 0.5 and 1 mm and two studies reported changes >1 
mm. Five studies reported mean PD values stratified by the initial PD, and found no apparent 
influence of deeper pockets at baseline (>7 mm) on changes in PD at the final evaluation. Two 
studies, however, reported higher PD increases at the final evaluation in initial deep pockets 
[35,41]. One publication reported a higher PD increase at molar sites than at non-molar 
sites [33]. Frequency distributions were used in 4 studies that reported the number of sites 
in each category of PD changes. Approximately 80% of the sites were found to have changes 
within 1 mm at the final evaluation [42]. Patients considered to have high susceptibility were 
https://doi.org/10.5051/jpis.2019.49.2.60
Periodontal disease progression after treatment
https://jpis.org 68
also found to have more sites with a PD change ≥2 mm [34]. Similarly, patients who showed 
erratic compliance presented a 20% higher prevalence of pockets ≥4 mm after 6 years than 
patients who regularly attended SPT [38].
Regarding the effect of the intervention in PD changes, MWF appeared to produce a greater 
mean PD reduction than SRP, but the differences dissipated as time progressed. One 
publication, however, observed that MWF was more effective than SRP in reducing the 
overall mean PD and in eliminating deep pockets [40]. One publication reported a greater PD 
reduction in deeper sites treated by FOS [43], while 2 studies found no long-term difference 
on PD levels for FOS when compared to other therapies [30,41].
The utilization of metronidazole or tetracycline as adjuncts to SRP did not appear to have an 
additional benefit in terms of PD changes after 5 years of therapy [36,37].
Furthermore, 4 studies reported tooth loss. The reasons for tooth loss included endodontic 
reasons, non-restorability, and periodontal disease progression. One publication reported 
that fewer than 1% of the extracted teeth were extracted for periodontal reasons [41], while 
another publication reported that in patients considered to have high susceptibility to 
periodontal disease, most tooth loss was associated with progressive periodontal disease, 
whereas in the non-susceptible group, endodontic reasons and caries were the most 
common reasons for tooth loss [34]. Finally, 3 studies reported radiographic outcomes, and 1 
publication reported microbiological outcomes 5 years after treatment.
DISCUSSION
The present systematic review found that the results achieved after surgical or non-surgical 
therapy were stable over a period of 5 years, as observed through the CAL measurements. 
Disease progression was circumscribed to limited sites and individuals. Progression was 
more frequent at proximal sites and molars, and in individuals with poor oral hygiene, those 
who showed poor compliance with recall, and smokers. The analysis of the influence of the 
treatment approach on the progression of periodontal disease yielded inconclusive results on 
the superiority of a particular technique or approach.
It must be taken into consideration that mean CAL values were reported after completion of 
active periodontal therapy and compared to those that occurred at the most recent follow-
up evaluation. Relying on mean values for making assessments of long-term treatment 
outcomes runs the risk of the numerous sites that remain stable overshadowing the relatively 
small percentage of sites that lose attachment. For this reason, the validity of using individual 
mean values to describe alterations of periodontal conditions during SPT following active 
periodontal therapy has been questioned [24].
It is precisely for the above-mentioned reasons that the authors refrained from performing 
a meta-analysis of the gathered data, and instead focused on reporting the frequency 
distribution of sites losing attachment and the yearly incidence of breakdown sites. A meta-
analysis on this secondary outcome could not be performed due to heterogeneity in the 
reporting of frequency distributions of sites that lost attachment and because the majority of 
the publications reported percentages and not on the overall number of sites that remained 
stable or lost attachment. Whenever possible, the CAL data were reported stratified by pocket 
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depth. This was done because shallow crevices are weighted heavily when computing overall 
patient means for CAL and PD, potentially masking what occurs at deeper sites.
Overall, sites with greater initial PD showed greater initial PD reduction and CAL gain, while 
at the most recent follow-up evaluation, shallow sites tended to lose attachment and deeper 
sites tended to show reduced CAL values. Although these findings are in agreement with 
recent longitudinal studies that have evaluated disease progression [14], it must be taken 
into consideration that tooth loss and reasons for tooth extraction were scarcely reported, 
meaning that disease progression, ultimately leading to tooth extraction, may have occurred 
at deep sites and gone unnoticed.
When evaluating the factors associated with disease progression through the incidence of sites 
losing attachment it became evident that oral hygiene, attendance to recall, and smoking were 
the most relevant factors. In patients with poor oral hygiene, 20% of sites had ≥2 mm of CAL 
loss, while in those with good oral hygiene, only 2%-3% of sites lost ≥2 mm [42]. Among the 
sites that lost CAL in patients who regularly attended SPT, 99% of the sites lost ≤1 mm of CAL, 
while in erratic compliers, 44% of the sites lost ≤1 mm and 55% lost 2–5 mm [38]. Similarly, 
when analyzing the patients that had an incidence of >3% of sites with ≥3 mm of CAL loss, all 
patients were found to have a smoking habit at baseline [31]. In addition, other factors such 
as the susceptibility to periodontal disease appeared to play a role; while in regular patients, 
10% of subjects had 8 teeth exhibiting ≥2 mm of CAL loss, 70% of those considered highly 
susceptible had >8 teeth with ≥2 mm of CAL [34]. These findings are in agreement with those 
reported by Fardal and colleagues [45], who analyzed the re-treatment profiles of patients 
during long-term SPT and concluded that the predictors of surgical re-treatment were poor 
compliance with SPT, a family history of periodontal disease, and poor prognosis at baseline. 
Equivalent results were found in a large population reporting an association between irregular 
compliance and recurrence rates of periodontitis [46], and smoking has been found to show 
an odds ratio of 10.7 for having ≥ 1 site with bone loss of ≥2 mm [47]. These findings highlight 
the importance of closely supervising patients who have been treated for periodontal disease, 
continuously monitoring oral hygiene, and emphasizing smoking cessation programs.
Furthermore, patients with a history of periodontal disease who have shown susceptibility to 
the disease process appear to be more likely to have new sites with CAL loss. Some reports 
have concluded that subjects under maintenance after periodontal therapy displayed more 
rapid attachment loss than periodontally healthy subjects, which indicates that, similarly to 
what has been found in untreated patients, healthy and diseased subjects may have different 
patterns of disease progression [48,49].
Although the objective of this systematic review was not to explore the effect of interventions, 
the present investigation found heterogeneous results with regard to the influence of the 
type of therapy provided at baseline in the development of further attachment loss. These 
findings are reasonable, given that the tested interventions were randomized per quadrant 
and pockets of different depths were included in each therapy, with no possibility of applying 
more interventional approaches to deeper sites and less invasive therapies for shallower 
sites in the same quadrant. In a recently published systematic review, it was concluded that 
surgical therapy led to significantly more CAL loss than non-surgical therapy in sites with 
shallow PD. In sites with moderate PD, MWF yielded significantly more PD reduction than 
SRP, and there was significantly less CAL gain with surgical therapy. Finally, in sites with 
deep PD, FOS led to significantly greater PD reduction than SRP [20].
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The conclusions of the present systematic review must be interpreted with caution, since it 
has been shown that factors assessed independently may not be valuable for predicting the 
risk of future attachment loss. Instead, the combination of factors in a multifactorial model 
may be useful for identifying individuals at risk for disease progression [26]. A number of 
multifactorial models for risk assessment have been developed, suggesting the need for a 
continuous multilevel risk assessment at the patient, tooth, and tooth site level to improve 
predictive power [50-54].
Nevertheless, the present systematic review highlights the importance of well-established 
classic periodontal concepts that are supported by the available evidence and that underscore 
the benefits of preventive measures such as attendance to SPT, reinforcement of plaque 
control, and promotion of smoking cessation programs to maintain the results achieved after 
surgical or non-surgical periodontal therapy.
CONCLUSIONS
The results obtained after surgical or non-surgical therapy in terms of CAL were stable over 
a period of 5 years. Disease progression was limited to a small number of patients, was more 
frequent at proximal sites and molar sites, and was associated with poor oral hygiene, poor 
compliance with recall, and smoking. The results of the present investigation highlight the 
importance of closely supervising patients who have been treated for periodontal disease, 
continuously monitoring oral hygiene, and emphasizing smoking cessation programs.
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